Immunology News and Research

Latest Immunology News and Research

Intensity and duration of SARS-CoV-2 immunity may depend on ABO blood group

A team of scientists from Canada and Spain recently evaluated the durability of antigen-specific immune responses in COVID-19 recovered individuals. They have also identified potential host factors associated with robust and long-lasting anti-SARS-CoV-2 immunity.

26 May 2021

Immunologists decode T cell responses that occur during COVID-19 infection

An international team of researchers from the Institute for Research in Biomedicine, affiliated to the Università della Svizzera italiana, has deciphered, at single cell resolution, the T cell responses occurring during COVID-19 infection.

26 May 2021

Human T cells can target more than 1,400 sites on SARS-CoV-2 virus

In a new paper, scientists from La Jolla Institute for Immunology (LJI) bring together research findings from COVID-19 researchers around the world.

25 May 2021

Study shows how neutralizing antibodies are produced after SARS-CoV-2 infection

A research group from Osaka University led by Professor Hisashi Arase and consisting of researchers from the Research Institute for Microbial Diseases, the Institute for Protein Research, the Immunology Frontier Research Center, the Center for Infectious Diseases, and the Graduate School of Medicine has discovered for the first time that both neutralizing antibodies that protect against infection as well as infection-enhancing antibodies that increase infectivity are produced after infection with SARS-CoV-2 by analyzing antibodies derived from COVID-19 patients.

25 May 2021

New collaborative effort to produce anti-HIV monoclonal antibodies

The Hotung Molecular Immunology group at St George's, University of London has partnered with Leaf Expression Systems, a contract development and manufacturing organization, specializing in plant-based expression and production of proteins, to explore the feasibility of producing anti-HIV monoclonal antibodies at large scale.

25 May 2021

Reduced levels of leptin are linked to poor vaccine responses in general population

Reduced levels of a metabolic hormone known as leptin is linked to poor vaccine antibody responses in the general population, a University of Queensland study has found.

24 May 2021

Mild cases of COVID-19 provide lasting antibody protection, shows study

Months after recovering from mild cases of COVID-19, people still have immune cells in their body pumping out antibodies against the virus that causes COVID-19, according to a study from researchers at Washington University School of Medicine in St. Louis. Such cells could persist for a lifetime, churning out antibodies all the while.

24 May 2021

Researchers investigate link between the liver’s immune system composition and NASH pathology

Our livers work hard to perform an entire range of activities: helping us digest food, maintaining body temperature and serving as an important checkpoint of the immune system for everything that we eat.

24 May 2021

STING agonist diABZI shows promise against SARS-CoV-2 variants

COVID-19 vaccines are the most effective way to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. For people who are already infected, new research suggests the small molecule stimulator of interferon genes (STING) agonist-1, diABZI, may be effective in controlling SARS-CoV-2 infection — including those caused by variants.

23 May 2021

Specific enzymes protect the human skin and body from microbes, viruses

The human body is constantly exposed to various environmental actors, from viruses to bacteria to fungi, but most of these microbial organisms provoke little or no response from our skin, which is charged with monitoring and protecting from external dangers.

22 May 2021

Parents and young adults urged to get HPV vaccination back on track

Sanford Burnham Prebys has joined doctors and scientists across America at National Cancer Institute (NCI)-designated cancer centers and other organizations to issue a joint statement urging the nation's physicians, parents and young adults to get the human papillomavirus (HPV) vaccination back on track.

21 May 2021

Scientists discover novel defensive response to SARS-CoV-2

Scientists from Hokkaido University have discovered a novel defensive response to SARS-CoV-2 that involves the viral pattern recognition receptor RIG-I. Upregulating expression of this protein could strengthen the immune response in COPD patients.

21 May 2021

Biognosys Announces the Appointment of Kristina Beeler as Chief Business Officer

Biognosys announces the appointment of Kristina Beeler as Chief Business Operator

From Biognosys 21 May 2021

Researchers speculate the low prevalence of COVID-19 in Japan

Protective immune memory--through B cells, which make antibodies, and/or T cells, which in the case of CD8+ T cells can kill virus-infected cells--can be induced by identical but also by related viruses.

20 May 2021

Blocking TGFβ1 could improve hematopoiesis in AML patients, indicates study

Bone marrow failure due to acute myeloid leukemia (AML) is a significant factor behind the disease's high rate of morbidity and mortality. Previous studies in mice suggest that AML cells inhibit healthy hematopoietic (blood) stem and progenitor cells (HSPC).

20 May 2021

Dupilumab considerably reduced asthma exacerbations in young children, shows VOYAGE trial

Results from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages 6-11 with uncontrolled moderate-to-severe asthma, compared to placebo, according to research presented at the ATS 2021 International Conference. VOYAGE (NCT02948959) is a recently completed randomized, placebo-controlled double-blind multicenter phase 3 clinical trial, that took place in a number of countries.

20 May 2021

Immunology News and Research

Latest Immunology News and Research

Intensity and duration of SARS-CoV-2 immunity may depend on ABO blood group

Immunologists decode T cell responses that occur during COVID-19 infection

Human T cells can target more than 1,400 sites on SARS-CoV-2 virus

Study shows how neutralizing antibodies are produced after SARS-CoV-2 infection

New collaborative effort to produce anti-HIV monoclonal antibodies

Reduced levels of leptin are linked to poor vaccine responses in general population

Mild cases of COVID-19 provide lasting antibody protection, shows study

Researchers investigate link between the liver’s immune system composition and NASH pathology

STING agonist diABZI shows promise against SARS-CoV-2 variants

Specific enzymes protect the human skin and body from microbes, viruses

Parents and young adults urged to get HPV vaccination back on track

Scientists discover novel defensive response to SARS-CoV-2

Biognosys Announces the Appointment of Kristina Beeler as Chief Business Officer

Researchers speculate the low prevalence of COVID-19 in Japan

Blocking TGFβ1 could improve hematopoiesis in AML patients, indicates study

Dupilumab considerably reduced asthma exacerbations in young children, shows VOYAGE trial

To the bat cave: In search of covid’s origins, scientists reignite polarizing debate on Wuhan ‘lab leak’

Toll-like receptor 2 (TLR2) detects the SARS-CoV-2 envelope protein and generates inflammatory cytokines

Study validates predictive model for identifying pediatric patients at risk for developing blood clots

Combination approach can improve the success rate of cancer treatment

eBook: The Ultimate Guide to Successful Immunofluorescence eBook

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics